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Abstract 
Background: Genetic vulnerability to environmental stressors is yet to be clarified in bipolar disorder (BD), a complex 
multisystem disorder in which immune dysfunction and infectious insults seem to play a major role in the patho‑
physiology. Association between pattern‑recognition receptor coding genes and BD had been previously reported. 
However, potential interactions with history of pathogen exposure are yet to be explored.
Methods: 138 BD patients and 167 healthy controls were tested for serostatus of Toxoplasma gondii, CMV, HSV‑1 and 
HSV‑2 and genotyped for TLR2 (rs4696480 and rs3804099), TLR4 (rs1927914 and rs11536891) and NOD2 (rs2066842) 
polymorphisms (SNPs). Both the pathogen‑specific seroprevalence and the TLR/NOD2 genetic profiles were com‑
pared between patients and controls followed by modelling of interactions between these genes and environmental 
infectious factors in a regression analysis.
Results: First, here again we observed an association between BD and Toxoplasma gondii (p = 0.045; OR = 1.77; 
95 % CI 1.01–3.10) extending the previously published data on a cohort of a relatively small number of patients (also 
included in the present sample). Second, we found a trend for an interaction between the TLR2 rs3804099 SNP and 
Toxoplasma gondii seropositivity in conferring BD risk (p = 0.017, uncorrected).
Conclusions: Pathogen exposure may modulate the influence of the immunogenetic background on BD. A much 
larger sample size and information on period of pathogen exposure are needed in future gene–environment interac‑
tion studies.
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Background
Bipolar disorder (BD) is a heritable chronic psychiat-
ric illness standing among the leading causes of dis-
ability worldwide (Collins et  al. 2011; Gore et  al. 2011; 
Whiteford et  al. 2013). The aetiology of BD is multifac-
torial and results from complex interactions between 
genetic determinants and a number of known and yet to 
be uncovered environmental factors (Kerner 2014). The 
index bipolar diagnosis is often delayed by many years 
as longitudinal natural history is one among the compo-
nents of diagnosis (Leboyer and Kupfer 2010). Currently, 
objective biomarkers that could lead to early and specific 
diagnosis of BD are lacking and identification of such 
markers along with objectively assessed environmental 
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factors could assist in tailoring reasoned preventive and 
therapeutic approaches for BD.
Studies on gene–environment interactions in psychiat-
ric disorders essentially focus on early-life psychosocial 
stressors as the environmental risk factor and to a limited 
extent on the infectious history of the mother (during 
pregnancy) or the foetus/neonate (Uher 2014). For exam-
ple, in BD, an interaction between BDNF gene polymor-
phisms and stressful life events seems to confer relatively 
higher risk for depressive episodes (Hosang et al. 2010). 
Similarly, maternal herpes simplex virus 2 (HSV-2) and 
cytomegalovirus (CMV) infectious history appears to 
interact, respectively, with GRIN2B and CTNNA3 gene 
polymorphisms to raise the risk of schizophrenia (SZ) 
(Børglum et  al. 2014; Demontis et  al. 2011). While the 
assessment of early-life stress may be subject to recall 
bias, history of infections is relatively amenable to objec-
tive evaluation. Indeed, in recent studies, infectious 
agents emerged as a group of well-defined environmen-
tal risk factors in psychiatric disorders and in particular 
in BD (Canetta et al. 2014; Dickerson et al. 2004; Ham-
dani et al. 2013; Parboosing et al. 2013). These studies not 
only stress the importance of studying infectious events 
but also, by decreasing the sample heterogeneity, allow to 
capture the environmental influence on genetic liability 
(Kazma et  al. 2011). Genetic susceptibility to infections 
is mediated by the inter-individual variability of immune 
responses, the first line defence being the innate immune 
system (Kotb et al. 2002; Pandey et al. 2014).
In this regard, genetic polymorphism of the pattern-
recognition receptors (PRRs) is of interest as PRRs rec-
ognize the pathogen-associated molecular patterns 
(PAMPs) (bacterial, viral, fungal or parasite-derived) as 
well as host-derived danger signals to provide optimal 
protection (Akira et al. 2006). We recently provided evi-
dence for associations between BD and genetic variants 
of TLR2, TLR4 and NOD2 genes, all encoding for pivotal 
PRRs (Oliveira et al. 2014a, b, c). The membrane-bound 
TLR2 and TLR4 and the cytoplasmic NOD2 receptors 
are widely expressed on immune cells, intestinal epithe-
lial cells and more importantly in microglia that actively 
participate in the central nervous system (CNS) homeo-
stasis and immune surveillance (Akira et  al. 2006; Ber-
rebi et al. 2003; Hanke and Kielian 2011; Lala et al. 2003; 
Olson and Miller 2004; Rivest 2009; Sterka and Marriott 
2006).
Although genetic associations between TLR2, TLR4 
and NOD2 polymorphisms with susceptibility to infec-
tions on the one hand (Schröder and Schumann 2005; 
Tekin et  al. 2012; van Well et  al. 2013), and BD (as dis-
cussed above) on the other have been independently 
reported in the literature, the influence of interaction 
between a particular infection and variability of the 
innate immune system on BD phenotype remains to be 
tested.
In order to explore possible gene–environment inter-
actions, the present study evaluates the effect of inter-
actions between serologically documented exposure to 
Toxoplasma gondii, CMV, HSV-1 or HSV-2 and poly-
morphisms of TLR2, TLR4 and NOD2 genes in a sample 
of patients with BD.
Methods
Subjects
This study included 138 cases (in- and out-patients) 
meeting the DSM-IV criteria (American Psychiatric 
Association 1994) for BD [type I, II or not otherwise 
specified (NOS)], from two French university-affiliated 
psychiatry departments (Mondor Hospital, Créteil, Uni-
versity Paris-Est and Fernand Widal Hospital, Paris, Uni-
versity Paris Diderot).
Patients were interviewed with the French version of 
the “Diagnostic Interview for Genetic Studies” (DIGS) for 
the assessment of lifetime clinical characteristics of BD 
as well as for demographic characteristics (i.e. number of 
years of education, working status, place of birth) (Nurn-
berger et  al. 1994). Ongoing treatments as well as hos-
pitalization status were recorded. Manic and depressive 
symptoms were assessed using, respectively, the Young 
Mania Rating Scale (Young et  al. 1978) and the Mont-
gomery–Åsberg Depression Rating Scale (Montgomery 
and Asberg 1979). In addition, 167 healthy controls were 
enrolled through a clinical investigation centre (Cen-
tre for Biological Resources, Mondor Hospital, Créteil, 
France). Only subjects without any personal or family 
history of psychotic disorders, affective disorders, addic-
tive or suicidal behaviour, or auto-immune diseases were 
included in the present study. Patients and controls were 
submitted to serological screening and were negative for 
HIV-1/-2, Hepatitis A, B and C and had no known recent 
inflammatory, auto-immune or infectious event or a neu-
rological disease. Knowing that Toxoplasma gondii infec-
tion incidence highly varies according to geographical 
location and assuming that potential early-life influences 
of Toxoplasma gondii may thus vary according to place 
of birth, a subsample including only individuals born in 
Metropolitan France was selected to study the associa-
tion between this parasite and BD. Indeed, to refine the 
genetic association analysis, a homogeneous subgroup of 
76 cases and 67 controls, with French ancestry (at least 
3 grandparents born in mainland France), was selected. 
Written informed consent was obtained from all partici-
pating subjects and the institutional ethical committee 
approved the research protocol.
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Serological analysis
Solid-phase enzyme microplate immunoassay meth-
ods were used to measure the IgG and IgM class anti-
bodies to Toxoplasma gondii, CMV, HSV-1 and HSV-2 
in blood samples using previously described methods 
(Yolken et al. 2001). Assay reagents were obtained from 
IBL America (Minneapolis, Minnesota, USA). The results 
were expressed as a ratio between the reactivity of the 
sample and a standard sample run on each microplate. 
Seropositivity was defined as a T. gondii IgG ratio ≥0.8, 
equivalent to ≥10 international units. All antibody meas-
urements were carried out at the Stanley Laboratory of 
Developmental Neurovirology, Baltimore, MD, USA. 
All samples were coded to ensure anonymity and the 
laboratory did not have access to diagnostic or clinical 
information.
TLR2, TLR4 and NOD2 genotyping
Genomic DNA was extracted from EDTA-treated periph-
eral blood sample using a standard procedure. Selection 
of analysed single-nucleotide polymorphisms (SNPs) of 
TLR2 (rs4696480 and rs3804099), TLR4 (rs1927914 and 
rs11536891) and NOD2 (rs2066842) were based on previ-
ous positive genetic association findings with BD subsets 
(Oliveira et al. 2014a, b, c). All SNPs were analysed by a 
pre-developed TaqMan® 5′-nuclease assay kits (Applied 
Biosystems®, Foster City, CA, USA) using allele-specific 
fluorogenic oligonucleotide probes as described earlier 
(Oliveira et al. 2014a, b, c).
Statistical analysis
The comparison of demographic/clinical characteris-
tics and Toxoplasma gondii, CMV, HSV-1 and HSV-2 
serological status between cases and controls was per-
formed using Chi-square tests for categorical variables 
and Mann–Whitney U tests for continuous variables. To 
correct for multiple testing (four serological markers), 
we used the Bonferroni approach to determine the sig-
nificance threshold (0.05/4 = 0.0125). According to these 
results, a multiple logistic regression analysis was further 
performed to test the association between Toxoplasma 
gondii seropositivity and BD diagnosis adjusting for age 
at inclusion and level of education (higher education vs 
other). This logistic regression analysis was similarly per-
formed in the subsample of individuals born in France.
Allelic frequency comparisons between cases and 
controls and testing for deviation from Hardy–Wein-
berg proportions in controls were performed using the 
Chi-square tests. Fisher’s exact test was used wherever 
appropriate.
To test for the potential gene–environment interaction 
between the studied SNPs of TLR2, TLR4 and NOD2 and 
Toxoplasma gondii serostatus, we modelled a multiple 
logistic regression incorporating an interaction term, also 
adjusting for age at inclusion and level of education. The 
number of minor alleles was included in the model as a 
continuous variable, in our additive genetic model. To 
correct for multiple testing (five SNPs), we used the Bon-
ferroni approach to determine the significance threshold 
(0.05/5 = 0.01). All associations were first tested for the 
whole sample and in a second step using only the sub-
sample of individuals of French ancestry (as described 
above). All statistical analyses were performed using the 
SPSS v20.0.0 and the WINPEPI v11.43 software packages 
(Abramson 2011).
Results
Demographic/clinical characteristics and allele distri-
butions in cases and controls are given, respectively, 
in Tables  1 and 3. The distribution of all the studied 
SNPs complied with the expected Hardy–Weinberg 
proportions.
We found a statistically significant association between 
BD and Toxoplasma gondii IgG seropositivity (univari-
ate p value  =  0.002) which was additionally confirmed 
by a multiple logistic regression analysis adjusting for 
age at inclusion and level of education (p value = 0.049; 
Table 1 Clinical and  demographic characteristics of  bipo-
lar and control subjects
BD bipolar disorder; HC healthy controls; NOS not otherwise specified; SD 
standard deviation; CMV cytomegalovirus; HSV-1 herpes simplex virus 1; HSV-2 
herpes simplex virus 2; NS non-significant
a Data were missing for three patients
BD (n = 138) HC (n = 167) p value
Mean ± SD
 Age at inclusion (years) 43.6 ± 13.50 39.5 ± 13.77 0.009
 Age at onset (years) (n = 135)a 26.3 ± 10.51 – –
n (%)
 Gender (female) 71 (51.4) 90 (53.9) 0.671
Diagnoses (DSM‑VI)
 BD‑I 98 (71.0) – –
 BD‑II 37 (26.8) – –
 BD‑NOS 3 (2.2) – –
Place of birth (Metropolitan 
France)
113 (81.9) 137 (82.0) 0.973
Education level (higher educa‑
tion)
78 (56.5) 72 (43.1) 0.020
Working status (currently active) 72 (52.2) 93 (55.7) 0.540
Serum anti‑pathogen IgG (positive)
Toxoplasma gondii 103 (74.6) 97 (58.1) 0.002
 CMV 84 (60.9) 107 (64.1) 0.565
 HSV‑1 34 (24.6) 47 (28.1) 0.490
 HSV‑2 87 (63.0) 119 (71.3) 0.127
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OR  =  1.77; 95  % CI 1.00–3.11) (Table  2). We also 
observed this association in the subgroup of patients 
born in France, similarly adjusting for age at inclusion 
and level of education (p value = 0.009; OR = 2.34; 95 % 
CI 1.23–4.43) (Table 2). This result confirms and extends 
the previously published data on a smaller set of French 
patients belonging to the same cohort and included in 
the present study (101 BD patients and 95 healthy con-
trols in common) (Hamdani et al. 2013).
None of the five SNPs studied in TLR2, TLR4 and 
NOD2 were significantly associated with BD, using an 
allelic or genotype model after accounting for multi-
ple testing and remained non-significant for the French 
ancestry subset (data not shown).
A trend for an interaction between TLR2 rs3804099 
and Toxoplasma gondii influencing the risk for BD was 
noted, although no longer significant after correction 
for multiple testing (Table 3). This SNP has an odds ratio 
below one in the Toxoplasma gondii seropositive group 
and the opposite in the seronegative group as assessed 
by separate logistic regression analyses with an additive 
model (Table 4).
Discussion
Inherited immune vulnerability to environmental risk 
factors may explain the association between BD and 
exposure to a variety of infections early in life, during a 
critical neurodevelopmental window (Canetta et al. 2014; 
Table 2 Association between  Toxoplasma gondii and  bipolar disorder adjusted for  age and  level of  education in  the 
whole sample
Level education = higher education vs other level of education
OR odds ratio; CI confidence interval; df degrees of freedom
Entire sample Individuals born in France
β OR CI 95 % df p value β OR CI 95 % df p value
Age 0.016 1.016 0.996–1.036 1 0.110 0.009 1.009 0.988–1.031 1 0.403
Level of education 0.629 1.876 1.172–3.003 1 0.009 0.656 1.928 1.144–3.248 1 0.014
Toxoplasma gondii 0.568 1.765 1.002–3.108 1 0.049 0.850 2.339 1.234–4.433 1 0.009
Table 3 TLR2, TLR4 and NOD2 polymorphisms in bipolar patients and healthy controls: genotype distribution
TLR2 Toll-like receptor 2; TLR4 Toll-like receptor 4; NOD2 nucleotide-binding oligomerization domain containing 2; BD bipolar disorder; NS non-significant; MAF minor 
allele frequency; HWE Hardy–Weinberg equilibrium in controls
Polymorphism MAF p value HWE p value
BD (n = 138) Controls (n = 167)
TLR2 rs4696480 T > A 0.46 0.51 0.178 0.929
TLR2 rs3804099 T > C 0.46 0.44 0.610 0.804
TLR4 rs1927914 A > G 0.41 0.39 0.601 0.671
TLR4 rs11536891 T > C 0.17 0.14 0.265 0.588
NOD2 rs2066842 C > T 0.25 0.25 0.898 0.656
Table 4 SNP x Toxoplasma gondii interaction
SNP single-nucleotide polymorphism; TG Toxoplasma gondii; MAF minor allele frequency; BD bipolar disorder; HC healthy controls; GxE gene–environment interaction; 
OR odds ratio; CI confidence interval
Polymorphism TG positive TG negative p value (GxE) OR TG (+) (CI 95 %) OR TG (−) (CI 95 %)
MAF BD MAF HC MAF BD MAF HC
TLR2 rs4696480 T/A 0.47 0.53 0.44 0.49 0.923 0.760 (0.51–1.14) 0.805 (0.44–1.47)
TLR2 rs3804099 T/C 0.42 0.45 0.59 0.43 0.021 0.894 (0.62–1.30) 2.289 (1.15–4.58)
TLR4 rs1927914 A/G 0.40 0.37 0.46 0.42 0.992 1.102 (0.76–1.60) 1.154 (0.65–2.05)
TLR4 rs11536891 T/C 0.17 0.11 0.17 0.18 0.341 1.546 (0.91–2.64) 0.944 (0.42–2.14)
NOD2 rs2066842 C/T 0.25 0.28 0.24 0.20 0.408 0.875 (0.56–1.37) 1.300 (0.64–2.63)
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Foldager et al. 2014; Graham et al. 2014; Hamdani et al. 
2013; Mazaheri-Tehrani et  al. 2014; Parboosing et  al. 
2013). Herein, we explored the interaction between infec-
tious stigma and genetic variants of the innate arm of the 
immune response in a sample of adult BD patients.
First, we confirmed the influence of Toxoplasma infec-
tion in BD by analysing a much larger sample than in a 
previous study (Table 1) and also by stringently selecting 
those born in France for sample homogeneity (Hamdani 
et  al. 2013). Second, we did not find a genetic associa-
tion between individual TLR2, TLR4 and NOD2 alleles 
and BD, as compared to our previous positive findings 
of association in a distinct study cohort (Oliveira et  al. 
2014a, b, c). Such discrepancy could possibly be related 
to differences in the study design. The present study 
involves a relatively smaller sample size, specifically 
when considering only individuals of French ancestry, 76 
cases and 67 controls. Such differing study setting may 
not necessarily have the power to detect the previously 
observed genetic associations, involving approximately 
550 and 200 cases and controls, respectively, and strin-
gently selected for their genetic homogeneity (at least 
three generations from mainland France) (Oliveira et al. 
2014a, b, c). However, it must be noted that the referred 
SNPs were not associated with BD in the large GWAS 
by the Psychiatric Genomics Consortium (7481 patients 
and 9250 controls) (Sklar et al. 2011). Third, in the gene–
environment interaction analysis, the TLR2 rs3804099/
Toxoplasma interaction shows a trend in that the TLR2 
genetic variation may modulate the relationship between 
Toxoplasma gondii exposure and BD.
Indeed, TLR2 molecules have been implicated: (i) in the 
perpetuation of inflammatory responses in the CNS after 
pro-inflammatory stimulation of astrocytes (Henn et  al. 
2011); (ii) in triggering neuro-inflammation in the pres-
ence of endogenous molecules such as α-synuclein and 
amyloid β-peptide, respectively, in Parkinson and Alzhei-
mer disorders (Kim et al. 2013; Liu et al. 2012); and (iii) 
in sustaining neuro-inflammation due to HSV-1 infection 
(Aravalli et  al. 2005). Besides these observations, asso-
ciation of TLR2 genetic diversity either with Alzheimer’s 
disease (Yu et al. 2011) or with cognitive function in SZ 
(Kang et  al. 2013) suggests that inter-individual liabil-
ity to modulate neuro-inflammation may be genetically 
driven. Yet direct evidence for the involvement of TLR2 
in susceptibility to Toxoplasma gondii and neuro-inflam-
mation is lacking. Nevertheless, a role for TLR2 is highly 
probable since higher loads of Toxoplasma gondii in brain 
tissue were observed in TLR2-deficient mice following 
infection with Toxoplasma gondii cysts (Mun et al. 2003).
We have recently described a combined effect of both 
TLR2 rs3804099 TT genotype and reported childhood 
sexual abuse on the age at onset of BD, a proxy of disease 
severity (Oliveira et  al. 2015). Additionally, in a murine 
model, prenatal immune priming (through the TLR3 
pathway) combined to peripubertal stress were shown to 
synergistically induce behavioural changes, unbalanced 
neurotransmitter levels, enhanced expression of markers 
of inflammation and microglia activation in stress-sensi-
tive brain areas of mice (Giovanoli et al. 2013). We may 
thus hypothesize that aberrant encounters viz infectious 
insults and/or psychosocial stress early in life may affect 
neurodevelopmental processes in genetically vulnerable 
individuals through a common mechanism involving 
inherited defective innate immune responses (Dickerson 
et al. 2014; Foldager et al. 2014).
In our study, it must be noted that the TLR2 
rs3804099/Toxoplasma gondii interaction term in the 
regression analysis was not statistically significant after 
correction for multiple comparisons. However, the trend 
found for the Toxoplasma gondii x TLR2 interaction and 
the observation that the TLR2 rs3804099 demonstrated 
an OR of 0.894 in the seropositive group and of 2.289 in 
the seronegative one emphasizes the pertinence of con-
sidering environmental risk factors when evaluating the 
genetic risk of BD and warrant replication using a much 
larger cohort. Another limitation of the present study is 
the absence of information regarding the ‘time window” 
of exposure to Toxoplasma gondii as we only have data 
on IgG antibodies.
Conclusions
We extend previously published data confirming the 
association between Toxoplasma gondii and BD on a 
much larger sample size and suggest that history of Tox-
oplasma exposure may modulate the influence of TLR2 
polymorphism on BD. A much larger sample size and 
better characterization of environmental risk exposure 
containing information on type, intensity and period of 
pathogen exposure are needed in future studies. If infec-
tions were ever to play a significant role in BD pathogen-
esis in interaction with host genetic liability, one would 
expect that appropriate and timely interventions on the 
environmental insults must be able to prevent or reduce 
the pathogenic load of BD highlighting the importance of 
gene-environment studies.
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